Product NDC: | 43353-035 |
Proprietary Name: | Prazosin Hydrochloride |
Non Proprietary Name: | Prazosin Hydrochloride |
Active Ingredient(s): | 2 mg/1 & nbsp; Prazosin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43353-035 |
Labeler Name: | Aphena Pharma Solutions - Tennessee, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071995 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091221 |
Package NDC: | 43353-035-60 |
Package Description: | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-035-60) |
NDC Code | 43353-035-60 |
Proprietary Name | Prazosin Hydrochloride |
Package Description | 90 CAPSULE in 1 BOTTLE, PLASTIC (43353-035-60) |
Product NDC | 43353-035 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Prazosin Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20091221 |
Marketing Category Name | ANDA |
Labeler Name | Aphena Pharma Solutions - Tennessee, Inc. |
Substance Name | PRAZOSIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |